Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

SPRINGROCK VENTURES
SeattleSeed–Late Stage$2M – $5M
16 people
Blume Ventures
MumbaiSeed–Late Stage$650K – $36M
21 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
12 people
First Analysis
ChicagoSeries A–Late Stage
24 people
BioAdvance
ConshohockenPre-Seed–Late Stage$500K – $1.5M
16 people
Panacea Venture
SingaporePre-Seed–Late Stage
22 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiPre-Seed–Late Stage$5.4M – $16.2M
12 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
28 people
Samsara BioCapital
Palo AltoSeed–Late Stage
7 people
Peregrine Ventures
Or YehudaSeed–Late Stage$500K – $3M
14 people
Next Level Ventures
Des MoinesSeed–Late Stage$500K – $5M
15 people
CEI Ventures
BrunswickSeed–Late Stage$1M – $4M
16 people
Illinois Ventures
ChampaignPre-Seed–Late Stage
19 people
Trendlines Group
MisgavPre-Seed–Late Stage$650K – $15M
18 people
Forbion
NaardenPre-Seed–Late Stage
23 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
8 people
Keio Innovation Initiative
TokyoSeed–Late Stage$1.5M – $64M
11 people
Black Opal Ventures
New YorkSeed–Late Stage
28 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
7 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
27 people
Visionaries Club
BerlinPre-Seed–Late Stage$900K
15 people
Broadview Ventures
BostonSeed–Late Stage
20 people
Investinor
TrondheimPre-Seed–Late Stage
32 people
Digitalis Ventures
New YorkSeed–Late Stage$100K – $10M
15 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.